https://www.avient.com/sites/default/files/resources/PolyOne%2520Investor%2520Presentation%2520Jefferies%25202013%2520Global%2520Industrial%2520Conference_Posting.pdf
Use of Non GAAP Measures Page 3 -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Strategy and Execution Drive Results Page 4 All time closing high of $29.48 August 1, 2013 • 15 consecutive quarters of double digit EPS growth • 42% CAGR adjusted EPS expansion 2006-2012 • YTD stock price has increased 42% versus 20% growth in the S&P 400% increase in market cap, from $0.7b to $2.8b since 2006 The World’s Premier Provider of Specialized Polymer Materials, Services & Solutions Four Pillar Strategy Page 5 PP&S 15% Specialty 60% Distribution 25% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010* 2011* 2012* 2015 Target Ad ju st ed E ar ni ng s P er S ha re Appliance 6% Building & Construction 13% Wire & Cable Electrical & Electronics 4% Consumer Packaging 18% Industrial 10% Misc. 5% HealthCare Transportation 16% Textiles 1% United States 70% Europe 14% Canada 8% Asia 5% Latin America 3% 2012 Revenues: $4.0 Billion* End Markets* 2012 Revenues: $4.0 Billion* EPS Page 6 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations PolyOne At A Glance * Restated to exclude discontinued operations Old PolyOne Transformation *Operating Income excludes corporate charges and special items **Pro Forma results include Spartech and Glasforms acquisitions, Specialty Coatings reclass and excludes discontinued operations 2% 34% 43% 45% 60% 62% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2012 2012 PF** H1'13 2015 % o f O pe ra tin g In co m e* JV's PP&S Distribution Specialty Specialty OI $5M $46M $87M $114M $150M $98M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 H1 2013 2015 Where we were Where we are Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.6% 12 – 16% Global Specialty Engineered Materials 1.1% 9.2% 12 – 16% Designed Structures & Solutions -- 4.4% 8 – 10% Performance Products & Solutions 5.4% 8.3% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 62% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 26% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 *Percentage of Specialty Platform revenue from products introduced in last five years 11.5% 46.5% 2006 Q2 2013 $20.3 $44.7 2006 TTM Q2'13 14.3% 31.1% 2006 Q2 2013 Research & Development Spending Specialty Platform Vitality Index Progression* Innovation Drives Earnings Growth ($ millions) Specialty Platform Gross Margin % Page 9 We are Experts in Polymer Science and Formulation Polymer Science Formulation Chemistry Processing Inputs Base Resins Additives Modifiers Colorants Specialized Polymer Materials, Services, and Solutions Expertise Satisfied Consumers PolyOne Customer Innovative Products & Services Marketplace Demands Performance Requirements Value Drivers Page 10 Positioned for Strong Growth 2015 Target Rev: $5B Adj.
https://www.avient.com/sites/default/files/2022-08/Avient Candidates Data Privacy Notice Final - Turkish.pdf
Bir pozisyon için başvurduğunuz yerel Avient kuruluşunun yasal mercisi kişisel bilgileriniz konusunda veri denetleyicisi olarak hareket edecektir. 1. Bize Ulaşın Herhangi bir sorunuz varsa veya haklarınızı kullanmak isterseniz bize aşağıdaki adresten ulaşabilirsiniz: Kurumsal Gizlilik Yetkilisi Avient Corporation 33587 Walker Road Avon Lake, Ohio 44012 E-posta: PRIVACY.OFFICER@AVIENT.COM Telefon: 1-800-901-2078 mailto:PRIVACY.OFFICER@AVIENT.COM Gizlilik sorularınız veya taleplerinizi bize çevrimiçi formumuzu doldurarak da gönderebilirsiniz. Geçerlilik Tarihi: 1 Ağustos 2020 https://privacyportal.onetrust.com/webform/b25cf7b1-a93a-4d26-8c84-ceda4d0ae91b/e180cbe4-d1b9-49bd-b621-cb5f6a0f42cb mailto:PRIVACY.OFFICER@AVIENT.COM
https://www.avient.com/sites/default/files/2021-04/versalloy-medical-tubing-case-study.pdf
The Avient team assessed the application’s technical and operational requirements, and recommended GLS Versalloy™ XL- 9045-1 alloy in 45 Shore A durometer, an FDA-compliant medical TPV grade designed for overmolding onto PP.
https://www.avient.com/sites/default/files/2020-07/core-powder-coatings-in-luxury-vehicles-case-study.pdf
When slush molding a door panel, vinyl powder is added to a hot mold, which melts the powder to a 1 mm-thick coating, and the mold then rotates so that the melted material can fill the entire cavity.
https://www.avient.com/sites/default/files/2020-11/controller-grip-case-study.pdf
According to the company, the precise thumb control and long-term comfort has made these new accessories “wildly popular.” 1 http://www.statista.com/statistics/237749/value-of-the-global- entertainment-and-media-market/ AVIENT HELPS GAMING ACCESSORIES COMPANY TAKE AIM AT NEW OPPORTUNITIES © 2020, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 To learn more, please contact Avient at +1.844.4AVIENT (1.844.428.4368)
https://www.avient.com/sites/default/files/2023-08/EVSE Industry Bulletin.pdf
Electric Vehicle (EV) Charging Market Solutions for Level 1, 2, and DC public charging equipment INDUSTRY BULLETIN With funding a priority for the industry, considerable growth of the infrastructure supporting the EV charging market is expected.
https://www.avient.com/sites/default/files/2023-06/Cesa_ Stat Antistatic Additives for Automotive - Application Bulletin.pdf
Cesa Stat Antistatic Additives for automotive can support customers with electrostatic decay time testing according to Standard DIN EN 61340-2-1 to speed up the development.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Bio-based Polymer Solutions Application Bulletin.pdf
KEY CHARACTERISTICS • Available for polyethylene, polypropylene, ABS, polycarbonate and styrenics • Bio-content of resin carrier varies from 70% to 100% depending on polymer—calculated to ASTM D6866 standard • Manufactured at four ISO 13485 certified sites, providing global consistency and security of supply • Documented change control beyond CAS number, reducing risk of change • Drop-in solutions that can be processed like fossil-based grades on common injection molding and extrusion machines • Can be provided as ready-to-use pre-colored or additive formulation REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP and (incl. class VI) - European Pharmacopeia, monograph 3.1.3/ 3.1.5 (polyolefin packaging materials) - USP (polyethylene) - Elemental impurities as per ICH Q3D • Registered Drug Master File (Type III) and/or Device Master File • Food contact according to US FDA and APPLICATION BULLETIN Sustainability Spotlight Bio-polymers Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2022-05/OnColor Non-Phtalate Color Concentrates for PVC Formulations Product Bulletin.pdf
PRODUCT SPECIFICATION PRODUCT BULLETIN CARRIER PVC Recommended % of use 1% Temperature resistance 200°C Dispersion - abaque Avient ≤ 2 Copyright © 2022, Avient Corporation.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives for Bormed Resins Application Bulletin.pdf
MEVOPUR COLORANTS • Standard colors in PP and PE to shorten time-to-market • Custom colors matched to Pantone, RAL or other color reference • White colorants for pharmaceutical packaging for LDPE, HDPE and PP with opacity to reach USP chapter MEVOPUR FUNCTIONAL ADDITIVES • Antistatic formulation with good flow/impact for injection molding • Amide- and amine-free antistatic for film in contact with API (Active Pharmaceutical Ingredients) • UV blocking for transparent PP and PE packaging to meet USP chapter • Non-migrating friction reduction/processing aid for PE and PP • Laser marking/welding additive for fast, reliable marking/assembly • MVTR (Moisture Vapor Transmission Rate) reduction for HDPE to improve shelf-life • Thermal protection of the polymer during processing • Gamma/e-beam sterilization protection for PP (up to 50kGy) with color compensation for reduced yellowing REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU* APPLICATION BULLETIN * FDA/EU compliance information available upon request Bormed™ is a registered trademark of Borealis Healthcare use limitations apply—see below.